- Borgen P O, Dahl O E, Reikeras O. Biomarkers of coagulation and fibrinolysis during cemented total hip arthroplasty with pre- versus postoperative start of thromboprophylaxis. Thrombosis 2013; 2013: 563217.
- Dahl O E, Quinlan D J, Bergqvist D J, Eikelboom J W. A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty. J Thromb Haemost 2010; 8: 1966–75.
- Ettema H B, Mulder M C, Nurmohamed M T, Buller H R, Verheyen C C. Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey. Acta Orthop 2009; 80(1): 109–12.
- Furnes O, Gjertsen JE, Hallan G, Visnes H, Gundersen T, Fenstad AM, Dybvik E, Bartz-Johannessen C. Annual report. Norwegian Arthroplasty Register 2018; http://nrlweb.ihelse.net/Rapporter/Rapport2018.pdf. p. 234
- Gjertsen J E, Engesaeter L B, Furnes O, et al. The Norwegian Hip Fracture Register: experiences after the first 2 years and 15,576 reported operations. Acta Orthop 2008; 79(5): 583–93.
- Gjertsen J E, Dybvik E, Furnes O, Fevang J M, Havelin L I, Matre K, Engesaeter L B. Improved outcome after hip fracture surgery in Norway. Acta Orthop 2017; 88(5): 505–11.
- Gomez-Outes A, Terleira-Fernandez A I, Suarez-Gea M L, Vargas-Castrillon E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ 2012; 344:e 3675.
- Kearon C, Hirsh J. Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 1995; 155:3 66–72.
- Lachiewicz P F. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Orthopedics 2009; 32: 74–8.
- Lassen M R, Gent M, Kakkar A K, et al. The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme. J Bone Joint Surg Br 2012; 94(11): 1573–8.
- Leer-Salvesen S, Dybvik E, Dahl O E, Gjertsen J-E, Engesaeter L B. Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures. Acta Orthop 2017; 88(1): 48–54
- Parvizi J, Ghanem E, Joshi A, Sharkey P F, Hozack W J, Rothman R H. Does “excessive” anticoagulation predispose to periprosthetic infection? J Arthroplasty 2007; 22: 24–8.
- Talsnes O, Hjelmstedt F, Dahl O E, Pripp A H, Reikeras O. Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly. Int Orthop 2011; 35(6): 903–7.
- Talsnes O, Vinje T, Gjertsen J E, et al. Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients. Int Orthop 2013; 37(6): 1135–40.
- Vera-Llonch M, Hagiwara M, Oster G. Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res 2006; 117(5): 569–77.
- Wiik R, Baste V, Gjertsen J E, Engesaeter L B Dekningsgradsanalyse for Nasjonalt Hoftebruddregister 2008-2012. Helsedirektoratet 13/11218. https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/675/Dekningsgradsanalyse-for-najonalt-hoftebruddregister-2008-2012-IS-2210.pdf
- Yoshida Rde A, Yoshida W B, Maffei F H, El Dib R, Nunes R, Rollo H A. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin. Ann Vas Surg 2013; 27(3): 355–69.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research